28 Results for "

squalene synthase

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "squalene synthase" in MCE Product Catalog:

27
27 Publications Verification
Cat. No.: HY-103087
CAS No.: 1083162-61-1
Purity:  98.03%
Target:  

Ferroptosis

Research Areas:  

Others

FIN56 is a specific inducer of ferroptosis. FIN56 induces ferroptosis by inducing degradation of GPX4. FIN56 also binds to and activates squalene synthase .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-100313A
CAS No.: 182959-33-7
Purity:  98.23%
Research Areas:  

Infection Metabolic Disease

YM-53601, a squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in vivo . YM-53601 inhibits squalene synthase derived from human hepatoma cells with an IC50 of 79 nM. Lipid-lowering agent . YM-53601 is also an inhibitor of farnesyl-diphosphate farnesyltransferase 1 (FDFT1) enzyme activity and abrogates HCV propagation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16274
CAS No.: 189060-13-7
Synonyms: TAK-475
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor, blocking the conversion of farnesyl diphosphate (FPP) to squalene in the cholesterol biosynthesis pathway . Lapaquistat acetate is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage. Lapaquistat acetate is used for hypercholesterolemia and mevalonate kinase deficiency (MKD) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116290
CAS No.: 142561-96-4
Purity:  99.2%
Synonyms: Squalestatin S1
Zaragozic acid A is a fungal metabolite that acts as a reversible competitive inhibitor of squalene synthase. Zaragozic acid A is an inhibitor of acute hepatic cholesterol synthesis in mouse (IC50 = 6 μM) .
loading...
    loading...
Cat. No.: HY-B2097
CAS No.: 138330-18-4
Synonyms: YM 175; Bisphonal
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

Incadronate disodium (YM 175) is a bisphosphonate with strong inhibitory activity on bone resorption. Incadronate disodium indirectly stimulates renal 25-hydroxyvitamin D-1-hydroxylase by increasing circulating parathyroid hormone. Incadronate disodium, a cholesterol-lowering agent, is a potent inhibitor of rat liver microsomal squalene synthase (Ki=57 nM). Incadronate disodium inhibits sterol biosynthesis in mouse macrophage J774 cells (IC50=64 μM). Incadronate disodium has the potential for malignant tumors research .
loading...
    loading...
Cat. No.: HY-100313
CAS No.: 182959-28-0
YM-53601 free base, a squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in vivo . YM-53601 free base inhibits squalene synthase derived from human hepatoma cells with an IC50 of 79 nM. Lipid-lowering agent . YM-53601 free base is also an inhibitor of farnesyl-diphosphate farnesyltransferase 1 (FDFT1) enzyme activity and abrogates HCV propagation .
loading...
    loading...
Cat. No.: HY-178158
CAS No.: 2306302-57-6
Research Areas:  

Cancer

SQS-IN-1 is a squalene synthase (SQS) inhibitor. SQS-IN-1 exhibits potent and broad-spectrum anti-proliferative effects on both mouse and human lung cancer cell lines. SQS-IN-1 inhibits DNA replication and the cell cycle, causing mitochondrial hyperpolarization and inducing cell apoptosis. SQS-IN-1 inhibits cell migration and invasion. SQS-IN-1 can be used to the study of lung cancer .
loading...
    loading...
Cat. No.: HY-149405
Target:  

Others

Research Areas:  

Metabolic Disease

Squalene synthase-IN-1 (compound 1) is a potent antihyperlipidemic agent acting through Squalene Synthase inhibition. Squalene synthase-IN-1 exhibits an outstanding antioxidant and anti-inflammatory activity. Squalene synthase-IN-1 displays a significant reduction not only of glucose but also of oxidative stress levels, while it did not cause any toxicity .
loading...
    loading...
Cat. No.: HY-163452
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

Squalene synthase-IN-2 (comppund isomer A-(1S, 3R)-14i) is an orally active squalene synthase inhibitor with IC50 values of 3.4, 99 nM for squalene synthase and cholesterol synthesis, respectively. Squalene synthase-IN-2 reduces plasma cholesterol and triglyceride .
loading...
    loading...
Cat. No.: HY-116290A
CAS No.: 144541-82-2
Synonyms: Squalestatin S1 trisodium
Research Areas:  

Others

Zaragozic acid A trisodium is a fungal metabolite that acts as a reversible competitive inhibitor of squalene synthase .
loading...
    loading...
Cat. No.: HY-124374
CAS No.: 162037-54-9
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

J-104123 is an inhibitor of squalene synthase with monocarboxylic acid structure. J-104123 can lower serum cholesterol level in dog models .
loading...
    loading...
Cat. No.: HY-16108A
CAS No.: 157126-15-3
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

BMS-187745 tripotassium (Compound 1) is a potent squalene synthase inhibitor .
loading...
    loading...
Cat. No.: HY-126871
CAS No.: 155179-15-0
Zaragozic acid D2 is the inhibitor for squalene synthase and Ras farnesyl-protein transferase (Ras FPTase), with IC50 of 2 nM and 100 nM, respectively. Zaragozic acid D2 is potentially ameliorating hypercholesterolemia and Ras-induced cancer .
loading...
    loading...
Cat. No.: HY-116595
CAS No.: 172277-82-6
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

J-104118 is a potent and orally active squalene synthase (SQS) inhibitor with an IC50 of 0.52 nM. J-104118 inhibits cholesterol synthesis in mice. J-104118 can be used for cholesterol-lowering research .
loading...
    loading...
Cat. No.: HY-123404
CAS No.: 172722-09-7
Research Areas:  

Infection

L-731128 is a novel alkyl citrate. L-731128 can be isolated as a minor component of Sporormiella intermedia (MF 5447, ATCC 20985) fermentations. L-731128 is a potent squalene synthase inhibitor, with an IC50 value of 767 nM .
loading...
    loading...
Cat. No.: HY-178088
CAS No.: 2232226-16-1
L-731120 is an alkyl citrate zargozaga acid A analogue, which is secondary metabolite produced by fungal fermentation. L-731120 shows inhibitory activity against squalene synthase (SQS) (IC50 = 260 nM). L-731120 can inhibit the synthesis of cholesterol in the liver. L-731120 can be used for the research of infection and metabolic disease, such as hypercholesterolemia .
loading...
    loading...
Cat. No.: HY-100299A
CAS No.: 190841-57-7
RPR107393 is an orally active potent selective squalene synthase (SQS) inhibitor. RPR107393 inhibits rat liver microsomal squalene synthase with an IC50 value of 0.8 nM. RPR107393 reduces triglyceride biosynthesis by suppressing fatty acid biosynthesis via an increase in intracellular farnesol and its derivatives. RPR107393 reduces plasma cholesterol in rats and marmosets. RPR107393 can be used for metabolic disease research, such as hypercholesterolemia, hypertriglyceridemia and atherosclerosis .
loading...
    loading...
Cat. No.: HY-100299
CAS No.: 197576-78-6
RPR107393 free base is an orally active potent selective squalene synthase (SQS) inhibitor. RPR107393 free base inhibits rat liver microsomal squalene synthase with an IC50 value of 0.8 nM. RPR107393 free base reduces triglyceride biosynthesis by suppressing fatty acid biosynthesis via an increase in intracellular farnesol and its derivatives. RPR107393 free base reduces plasma cholesterol in rats and marmosets. RPR107393 free base can be used for metabolic disease research, such as hypercholesterolemia, hypertriglyceridemia and atherosclerosis [1][2].
loading...
    loading...
Cat. No.: HY-N13888
CAS No.: 163564-55-4
Schizostatin is a squalene synthase inhibitor with an IC50 of 0.84 μM .
loading...
    loading...
Cat. No.: HY-125324
CAS No.: 142505-92-8
Squalestatin 3 is a secondary metabolite, which can be isolated from Phoma. Squalestatin 3 is an inhibitor for squalene synthase with an IC50 of 6 nM .
loading...
    loading...